Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-06-30

Clinical Trial Update: Evaluating the Efficacy of Vardenafil in Subjects With Erectile Dysfunction (ED) Administered 12, 18 or 24 Hours Prior to Intercourse [Phase 4]

View source ↗

Summary

A Phase 4 trial from Bayer evaluated the efficacy of vardenafil when given 12, 18, or 24 hours before intercourse in men with erectile dysfunction; the study is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levitra (vardenafil)

Snippet

Sponsor: Bayer | Conditions: Erectile Dysfunction | Phase 4 | Status: COMPLETED